In the realm of biotech, News Corporation (NWSA) has been making significant moves that are drawing investor attention. Prominently, actions by aggressive player Starboard are seeking to disrupt the established dual class stock structure, in an attempt to challenge media mogul Rupert Murdoch's control. News Corp displayed an assertive response by announcing a massive $1 billion buy-back plan for its own shares effectively expanding their share repurchase program. This sizable initiative follows a period of lukewarm advertising revenues, counteracted somewhat by surges in digital subscriptions. News Corp's CFO made a substantial personal investment of over $1.55 million in the company, suggesting internal confidence in future performance. Concomitantly, the company has been noted as an innovator in the application of AI to its services, a development that may further augment its standing in the market. Lastly, the company has embarked on a significant collaboration with OpenAI, leveraging their artificial intelligence technology for journalistic content improvement.
